Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[Combining cytogenetic complexity and transcript data, we found that the subgroup of patients with tumors showing simple karyotypes and SYT/SSX2 fusion had the best clinical outcome (2/8 patients developed metastases), and those with tumors showing complex karyotypes together with SYT/SSX1 fusion the worst (6/7 patients developed metastases).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP282278.RAHCCQFihCyDn1a8OxGr-UL9L9U0nEaxMAlzMy8iv9yFQ130_assertion description "[Combining cytogenetic complexity and transcript data, we found that the subgroup of patients with tumors showing simple karyotypes and SYT/SSX2 fusion had the best clinical outcome (2/8 patients developed metastases), and those with tumors showing complex karyotypes together with SYT/SSX1 fusion the worst (6/7 patients developed metastases).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP282278.RAHCCQFihCyDn1a8OxGr-UL9L9U0nEaxMAlzMy8iv9yFQ130_provenance.
• NP714724.RAYKpr8hoS7YDydT5YRjZHY50IX7ldXNpAGeWAcOHgUc8130_assertion description "[Combining cytogenetic complexity and transcript data, we found that the subgroup of patients with tumors showing simple karyotypes and SYT/SSX2 fusion had the best clinical outcome (2/8 patients developed metastases), and those with tumors showing complex karyotypes together with SYT/SSX1 fusion the worst (6/7 patients developed metastases).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP714724.RAYKpr8hoS7YDydT5YRjZHY50IX7ldXNpAGeWAcOHgUc8130_provenance.
• NP714803.RAeAVii9iyuFNltQWRd-GqChh9gD_DBJ0BRu6hOzkQY-w130_assertion description "[Combining cytogenetic complexity and transcript data, we found that the subgroup of patients with tumors showing simple karyotypes and SYT/SSX2 fusion had the best clinical outcome (2/8 patients developed metastases), and those with tumors showing complex karyotypes together with SYT/SSX1 fusion the worst (6/7 patients developed metastases).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP714803.RAeAVii9iyuFNltQWRd-GqChh9gD_DBJ0BRu6hOzkQY-w130_provenance.
• NP715011.RAcvqbxsmdH1b_y9eDhJXBC0viVyqaBjvnkEAxXS0PZcM130_assertion description "[Combining cytogenetic complexity and transcript data, we found that the subgroup of patients with tumors showing simple karyotypes and SYT/SSX2 fusion had the best clinical outcome (2/8 patients developed metastases), and those with tumors showing complex karyotypes together with SYT/SSX1 fusion the worst (6/7 patients developed metastases).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP715011.RAcvqbxsmdH1b_y9eDhJXBC0viVyqaBjvnkEAxXS0PZcM130_provenance.
• NP721361.RAYGQrPVtfubhMGxikJcJe_3ZKUMnnzId0ABckD8fJt18130_assertion description "[Combining cytogenetic complexity and transcript data, we found that the subgroup of patients with tumors showing simple karyotypes and SYT/SSX2 fusion had the best clinical outcome (2/8 patients developed metastases), and those with tumors showing complex karyotypes together with SYT/SSX1 fusion the worst (6/7 patients developed metastases).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP721361.RAYGQrPVtfubhMGxikJcJe_3ZKUMnnzId0ABckD8fJt18130_provenance.
• assertion description "[Combining cytogenetic complexity and transcript data, we found that the subgroup of patients with tumors showing simple karyotypes and SYT/SSX2 fusion had the best clinical outcome (2/8 patients developed metastases), and those with tumors showing complex karyotypes together with SYT/SSX1 fusion the worst (6/7 patients developed metastases).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Combining cytogenetic complexity and transcript data, we found that the subgroup of patients with tumors showing simple karyotypes and SYT/SSX2 fusion had the best clinical outcome (2/8 patients developed metastases), and those with tumors showing complex karyotypes together with SYT/SSX1 fusion the worst (6/7 patients developed metastases).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Combining cytogenetic complexity and transcript data, we found that the subgroup of patients with tumors showing simple karyotypes and SYT/SSX2 fusion had the best clinical outcome (2/8 patients developed metastases), and those with tumors showing complex karyotypes together with SYT/SSX1 fusion the worst (6/7 patients developed metastases).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Combining cytogenetic complexity and transcript data, we found that the subgroup of patients with tumors showing simple karyotypes and SYT/SSX2 fusion had the best clinical outcome (2/8 patients developed metastases), and those with tumors showing complex karyotypes together with SYT/SSX1 fusion the worst (6/7 patients developed metastases).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP721195.RAqy-0N5iTGjtkg4pBA1PeYLw6JbawsJcKwCwOmk_v-xk130_assertion description "[Combining cytogenetic complexity and transcript data, we found that the subgroup of patients with tumors showing simple karyotypes and SYT/SSX2 fusion had the best clinical outcome (2/8 patients developed metastases), and those with tumors showing complex karyotypes together with SYT/SSX1 fusion the worst (6/7 patients developed metastases).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP721195.RAqy-0N5iTGjtkg4pBA1PeYLw6JbawsJcKwCwOmk_v-xk130_provenance.
• NP322546.RACiMbekTxzme8XRA-vof1XfzmJxkln_wny-Ue31CCqew130_assertion description "[Combining cytogenetic complexity and transcript data, we found that the subgroup of patients with tumors showing simple karyotypes and SYT/SSX2 fusion had the best clinical outcome (2/8 patients developed metastases), and those with tumors showing complex karyotypes together with SYT/SSX1 fusion the worst (6/7 patients developed metastases).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP322546.RACiMbekTxzme8XRA-vof1XfzmJxkln_wny-Ue31CCqew130_provenance.
• NP714898.RAjfnZqgOqvfBV6fT_OQcQxZEQr7FsBkIokq4K81ljDRk130_assertion description "[Combining cytogenetic complexity and transcript data, we found that the subgroup of patients with tumors showing simple karyotypes and SYT/SSX2 fusion had the best clinical outcome (2/8 patients developed metastases), and those with tumors showing complex karyotypes together with SYT/SSX1 fusion the worst (6/7 patients developed metastases).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP714898.RAjfnZqgOqvfBV6fT_OQcQxZEQr7FsBkIokq4K81ljDRk130_provenance.
• NP322543.RAe6fvbEFq_9RNoJ_ip6SKuCevozskz2DVRyvlpsJSsGE130_assertion description "[Combining cytogenetic complexity and transcript data, we found that the subgroup of patients with tumors showing simple karyotypes and SYT/SSX2 fusion had the best clinical outcome (2/8 patients developed metastases), and those with tumors showing complex karyotypes together with SYT/SSX1 fusion the worst (6/7 patients developed metastases).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP322543.RAe6fvbEFq_9RNoJ_ip6SKuCevozskz2DVRyvlpsJSsGE130_provenance.
• NP322545.RAbdl2Ea4gmDA9-3OUza3ajSt3RADZIG4USjy8eJYW8Bk130_assertion description "[Combining cytogenetic complexity and transcript data, we found that the subgroup of patients with tumors showing simple karyotypes and SYT/SSX2 fusion had the best clinical outcome (2/8 patients developed metastases), and those with tumors showing complex karyotypes together with SYT/SSX1 fusion the worst (6/7 patients developed metastases).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP322545.RAbdl2Ea4gmDA9-3OUza3ajSt3RADZIG4USjy8eJYW8Bk130_provenance.
• NP1009243.RAoiZWm-h1Y7GE-dPgm-F2RsE-4gWPqZQxgp67dQqlgfk130_assertion description "[Combining cytogenetic complexity and transcript data, we found that the subgroup of patients with tumors showing simple karyotypes and SYT/SSX2 fusion had the best clinical outcome (2/8 patients developed metastases), and those with tumors showing complex karyotypes together with SYT/SSX1 fusion the worst (6/7 patients developed metastases).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1009243.RAoiZWm-h1Y7GE-dPgm-F2RsE-4gWPqZQxgp67dQqlgfk130_provenance.
• NP1009337.RAl_CzIosAqivF6_P0a0FIvHvJacQRjwlgMwD7DWmOWko130_assertion description "[Combining cytogenetic complexity and transcript data, we found that the subgroup of patients with tumors showing simple karyotypes and SYT/SSX2 fusion had the best clinical outcome (2/8 patients developed metastases), and those with tumors showing complex karyotypes together with SYT/SSX1 fusion the worst (6/7 patients developed metastases).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1009337.RAl_CzIosAqivF6_P0a0FIvHvJacQRjwlgMwD7DWmOWko130_provenance.
• NP714943.RALMM4tqP2ik8EMByFyFThK35GdEFajlwv6WXVS2Q38NE130_assertion description "[Combining cytogenetic complexity and transcript data, we found that the subgroup of patients with tumors showing simple karyotypes and SYT/SSX2 fusion had the best clinical outcome (2/8 patients developed metastases), and those with tumors showing complex karyotypes together with SYT/SSX1 fusion the worst (6/7 patients developed metastases).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP714943.RALMM4tqP2ik8EMByFyFThK35GdEFajlwv6WXVS2Q38NE130_provenance.
• NP714761.RA9IvjrWqAgycCuNc_2KbnTU4nmVjko8Ik3vVsEBZLK4Q130_assertion description "[Combining cytogenetic complexity and transcript data, we found that the subgroup of patients with tumors showing simple karyotypes and SYT/SSX2 fusion had the best clinical outcome (2/8 patients developed metastases), and those with tumors showing complex karyotypes together with SYT/SSX1 fusion the worst (6/7 patients developed metastases).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP714761.RA9IvjrWqAgycCuNc_2KbnTU4nmVjko8Ik3vVsEBZLK4Q130_provenance.
• NP322542.RA76sGB4RPbcKoBQw9Lx_Q4_9bnjZ94V7lwDhA0twFeqo130_assertion description "[Combining cytogenetic complexity and transcript data, we found that the subgroup of patients with tumors showing simple karyotypes and SYT/SSX2 fusion had the best clinical outcome (2/8 patients developed metastases), and those with tumors showing complex karyotypes together with SYT/SSX1 fusion the worst (6/7 patients developed metastases).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP322542.RA76sGB4RPbcKoBQw9Lx_Q4_9bnjZ94V7lwDhA0twFeqo130_provenance.
• NP322547.RA3GAydo9qSEtaJjnatRtKzUoRmuJff4ykrzp8V-4RPtw130_assertion description "[Combining cytogenetic complexity and transcript data, we found that the subgroup of patients with tumors showing simple karyotypes and SYT/SSX2 fusion had the best clinical outcome (2/8 patients developed metastases), and those with tumors showing complex karyotypes together with SYT/SSX1 fusion the worst (6/7 patients developed metastases).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP322547.RA3GAydo9qSEtaJjnatRtKzUoRmuJff4ykrzp8V-4RPtw130_provenance.